Tvardi Therapeutics, Inc.
TVRD
$3.75
-$0.16-4.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.53M | 4.17M | -9.58M | -12.71M | -5.51M |
| Total Depreciation and Amortization | 24.00K | 23.00K | 24.00K | 24.00K | 24.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 332.00K | -12.08M | 5.53M | 2.07M | 95.00K |
| Change in Net Operating Assets | 914.00K | 2.03M | -3.66M | 5.78M | -1.26M |
| Cash from Operations | -4.26M | -5.87M | -7.69M | -4.83M | -6.66M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.35M | -9.55M | -10.88M | -- | -- |
| Cash from Investing | 5.35M | -9.55M | -10.88M | -- | -- |
| Total Debt Issued | -- | -- | -- | 28.30M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 107.00K | 421.00K | 3.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -429.00K | 24.21M | -1.61M | -1.29M | -14.00K |
| Cash from Financing | -322.00K | 24.63M | -1.60M | 27.01M | -14.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 770.00K | 9.21M | -20.18M | 22.18M | -6.67M |